Protective Effect of 2'-Fucosyllactose on Necrotizing Enterocolitis and Infectious Diarrhea in Infants

LU Menglan; CHEN Cailong; XU Jiaying; SHI Yujie; SU Hongwen; LIU Biao; QIN Liqiang

doi:10.13386/j.issn1002-0306.2020100239

Volume 42 Issue 23

Nov. 2021

Turn off MathJax

Article Contents

Abstract

References

Science and Technology of Food Industry > 2021 > 42(23): 408-412. > DOI: 10.13386/j.issn1002-0306.2020100239

LU Menglan, CHEN Cailong, XU Jiaying, et al. Protective Effect of 2'-Fucosyllactose on Necrotizing Enterocolitis and Infectious Diarrhea in Infants[J]. Science and Technology of Food Industry, 2021, 42(23): 408−412. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2020100239.

Citation:

PDF (1972 KB)

Protective Effect of 2'-Fucosyllactose on Necrotizing Enterocolitis and Infectious Diarrhea in Infants

1.
School of Public Health, Soochow University, Suzhou 215123, China
2.
School of Radiation Medicine and Protection, Soochow University, Suzhou 215123, China
3.
Jinshan Branch Company, Inner Mongolia Yili Industrial Group Co., Ltd., Hohhot 010110, China

More Information

Received Date: October 28, 2020
Available Online: September 23, 2021

Graphical Abstract

Abstract

Abstract

Infants, especially newborns, have poor digestion and immune function and immature intestinal development, leading to poor intestinal tolerance and difficulty in bacterial colonization, and highly sensitivity to necrotizing enterocolitis and infectious diarrhea. The benefits of breast feeding for infant intestinal health depend on a special oligosaccharide, and 2'-fucosyllactose (2'-FL) is the higher content of oligosaccharides. This paper describes the safety of 2'-FL, regulation of intestinal flora and immune system, and its protective effect on necrotizing enterocolitis and infectious diarrhea in infants.
- 2'-fucosyllactose,
- human milk oligosaccharides,
- diarrhea,
- necrotizing enterocolitis,
- infant formula

FullText(HTML)

References (55)

References

[1]	BODE L. Human milk oligosaccharides: Every baby needs a sugar mama[J]. Glycobiology,2012,22(9):1147−1162. doi: 10.1093/glycob/cws074
[2]	VANDENPLAS Y, BERGER B, CARNIELLI V P, et al. Human milk oligosaccharides: 2'-fucosyllactose (2’-FL) and Lacto-N-Neotetraose (LNnT) in infant formula[J]. Nutrients,2018,10(9):1161. doi: 10.3390/nu10091161
[3]	KONG C L, FAAS MM, DEVOS P, et al. Impact of dietary fibers in infant formulas on gut microbiota and the intestinal immune barrier[J]. Food & Function,2020,11(11):9445−9467.
[4]	PATEL R M, DENNING P W. Intestinal microbiota and its relationship with necrotizing enterocolitis[J]. Pediatric Research,2015,78(3):232−238. doi: 10.1038/pr.2015.97
[5]	BERING S B. Human milk oligosaccharides to prevent gut dysfunction and necrotizing enterocolitis in preterm neonates[J]. Nutrients,2018,10(10):1461. doi: 10.3390/nu10101461
[6]	SAMUEL T M, BINIA A, DE CASTRO C A, et al. Impact of maternal characteristics on human milk oligosaccharide composition over the first 4 months of lactation in a cohort of healthy European mothers[J]. Scientific Reports,2019,9(1):11767. doi: 10.1038/s41598-019-48337-4
[7]	YAN J, DING J, JIN G, et al. Profiling of human milk oligosaccharides for Lewis epitopes and secretor status by electrostatic repulsion hydrophilic interaction chromatography coupled with negative-Ion electrospray tandem mass spectrometry[J]. Analytical Chemistry,2019,91(13):8199−8206. doi: 10.1021/acs.analchem.9b00687
[8]	LEFEBVRE G, SHEVLYAKOVA M, CHARPAGNE A, et al. Time of lactation and maternal fucosyltransferase genetic polymorphisms determine the variability in human milk oligosaccharides[J]. Frontiers in Nutrition,2020,7:574459. doi: 10.3389/fnut.2020.574459
[9]	COULET M, PHOTHIRATH P, ALLAIS L, et al. Pre-clinical safety evaluation of the synthetic human milk, nature-identical, oligosaccharide 2′-O-fucosyllactose (2′FL)[J]. Regulatory Toxicology and Pharmacology,2014,68(1):59−69. doi: 10.1016/j.yrtph.2013.11.005
[10]	潘丽娜, 李泽, 郁欢欢, 等. 配方奶粉中添加2'-岩藻糖基乳糖对小鼠消化吸收功能影响[J]. 中国乳品工业,2019,47(10):20−23. [PAN L N, LI Z, YU H H, et al. Effect of 2' -fucosyllactose added to formula milk powder on digestion and absorption function of mice[J]. Chinese Dairy Industry,2019,47(10):20−23. doi: 10.3969/j.issn.1001-2230.2019.10.004
[11]	MARRIAGE B J, BUCK R H, GOEHRING K C, et al. Infants fed a lower calorie formula with 2'-FL show growth and 2'-FL uptake like breast-fed infants[J]. Journal of Pediatric Gastroenterology and Nutrition,2015,61(6):649−658. doi: 10.1097/MPG.0000000000000889
[12]	JUNG S M, CHIN Y W, LEE Y G, et al. Enhanced production of 2'-fucosyllactose from fucose by elimination of rhamnose isomerase and arabinose isomerase in engineered Escherichia coli[J]. Biotechnology and Bioengineering,2019,116(9):2412−2417. doi: 10.1002/bit.27019
[13]	SPRENGER G A, BAUMGARTNER F, ALBERMANN C. Production of human milk oligosaccharides by enzymatic and whole-cell microbial biotransformations[J]. Journal of Biotechnology,2017,258:79−91. doi: 10.1016/j.jbiotec.2017.07.030
[14]	PEREZ-ESCALANTE E, ALATORRE-SANTAMARIA S, CASTANEDA-OVANDO A, et al. Human milk oligosaccharides as bioactive compounds in infant formula: Recent advances and trends in synthetic methods[J]. Critical Reviews in Food Science and Nutrition,2020:1−34.
[15]	SALMINEN S. Regulatory aspects of human milk oligosaccharides[J]. Nestle Nutrition Institute Workshop Series,2017,88:161−170.
[16]	TURCK D, CASTENMILLER J, DE HENAUW S, et al. Safety of 2'-fucosyllactose/difucosyllactose mixture as a novel food pursuant to Regulation (EU) 2015/2283[J]. EFSA Journal European Food Safety Authority,2019,17(6):e05717.
[17]	HOLSCHER HD, BODE L, TAPPENDEN KA. Human milk oligosaccharides influence intestinal epithelial cell maturation in vitro[J]. Journal of Pediatric Gastroenterology and Nutrition,2017,64(2):296−301. doi: 10.1097/MPG.0000000000001274
[18]	AZAGRA-BORONAT I, MASSOT-CLADERA M, MAYNERIS-PERXACHS J, et al. Immunomodulatory and prebiotic effects of 2'-Fucosyllactose in suckling rats[J]. Frontiers in Immunology,2019,10:1773−1773. doi: 10.3389/fimmu.2019.01773
[19]	CHLEILAT F, KLANCIC T, MA K, et al. Human milk oligosaccharide supplementation affects intestinal barrier function and microbial composition in the gastrointestinal tract of young sprague Dawley rats[J]. Nutrients,2020,12(5):1532.
[20]	GALAZZO G, VAN BEST N, BERVOETS L, et al. Development of the microbiota and associations with birth mode, diet, and atopic disorders in a longitudinal analysis of stool samples, collected from infancy through early childhood[J]. Gastroenterology,2020,158(6):1584−1596. doi: 10.1053/j.gastro.2020.01.024
[21]	LUGLI GA, DURANTI S, MILANI C, et al. Investigating bifidobacteria and human milk oligosaccharide composition of lactating mothers[J]. FEMS Microbiology Ecology,2020,96(5):fiaa049. doi: 10.1093/femsec/fiaa049
[22]	PAMMI M, COPE J, TARR PI, et al. Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: A systematic review and meta-analysis[J]. Microbiome,2017,5(1):31. doi: 10.1186/s40168-017-0248-8
[23]	ZHANG G, ZHAO J, WEN R, et al. 2'-Fucosyllactose promotes bifidobacterium bifidum DNG6 adhesion to Caco-2 cells[J]. Journal of Dairy Science,2020,103(11):9825−9834. doi: 10.3168/jds.2020-18773
[24]	SALLI K, ANGLENIUS H, HIRONEN J, et al. The effect of 2'-fucosyllactose on simulated infant gut microbiome and metabolites; a pilot study in comparison to GOS and lactose[J]. Scientific Reports,2019,9(1):13232. doi: 10.1038/s41598-019-49497-z
[25]	SALLI K, HIRVONEN J, SIITONEN J, et al. Selective utilization of the hman milk oligosaccharides 2'-Fucosyllactose, 3'-Fucosyllactose, and difucosyllactose by various probiotic and pathogenic bacteria[J]. Journal of Agricultural and Food Chemistry,2021,69(1):170−182. doi: 10.1021/acs.jafc.0c06041
[26]	HOLACHER H D. Dietary fiber and prebiotics and the gastrointestinal microbiota[J]. Gut Microbes,2017,8(2):172−184. doi: 10.1080/19490976.2017.1290756
[27]	LANGHORST J, KOCH A K, VOISS P, et al. Distinct patterns of short-chain fatty acids during flare in patients with ulcerative colitis under treatment with mesalamine or a herbal combination of myrrh, chamomile flowers, and coffee charcoal: Secondary analysis of a randomized controlled trial[J]. European Journal of Gastroenterology & Hepatology,2020,32(2):175−180.
[28]	HOEFLINGER J L, DAVIS S R, CHOW J, et al. In vitro impact of human milk oligosaccharides on Enterobacteriaceae growth[J]. Journal of Agricultural and Food Chemistry,2015,63(12):3295−3302. doi: 10.1021/jf505721p
[29]	MEDINA D A, PINTO F, ORTUZAR V, et al. Simulation and modeling of dietary changes in the infant gut microbiome[J]. FEMS Microbiology Ecology,2018,94(9).
[30]	SHOKRYAZDAN P, FASELEH JAHROMI M, NAVIDSHAD B, et al. Effects of prebiotics on immune system and cytokine expression[J]. Medical Microbiology and Immunology,2017,206(1):1−9. doi: 10.1007/s00430-016-0481-y
[31]	DONOVAN SM, COMSTOCK SS. Human milk oligosaccharides influence neonatal mucosal and systemic immunity[J]. Annals of Nutrition & Metabolism,2016,69 Suppl 2(Suppl2):42−51.
[32]	CASTILLO-COURTADE L, HAN S, LEE S, et al. Attenuation of food allergy symptoms following treatment with human milk oligosaccharides in a mouse model[J]. Allergy,2015,70(9):1091−1102. doi: 10.1111/all.12650
[33]	NOLL AJ, YU Y, LASANAJAK Y, et al. Human DC-SIGN binds specific human milk glycans[J]. The Biochemical Journal,2016,473(10):1343−1353. doi: 10.1042/BCJ20160046
[34]	AYECHU-MURUZABAL V, OVERBEEK SA, KOSTADINOVA AI, et al. Exposure of intestinal epithelial cells to 2'-Fucosyllactose and CpG enhances galectin release and instructs dendritic cells to drive Th1 and regulatory-type immune development[J]. Biomolecules,2020,10(5):784. doi: 10.3390/biom10050784
[35]	HE Y, LIU S, KLING DE, et al. The human milk oligosaccharide 2'-fucosyllactose modulates CD14 expression in human enterocytes, thereby attenuating LPS-induced inflammation[J]. Gut,2016,65(1):33−46. doi: 10.1136/gutjnl-2014-307544
[36]	XIAO L, LEUSINK-MUIS T, KETTELARIJ N, et al. Human milk oligosaccharide 2'-fucosyllactose improves innate and adaptive immunity in an influenza-specific murine vaccination model[J]. Frontiers in Immunology,2018,9:452. doi: 10.3389/fimmu.2018.00452
[37]	PATEL A L, PANAGOS P G, SILVESTRI J M. Reducing incidence of necrotizing enterocolitis[J]. Clinics in Perinatology,2017,44(3):683−700. doi: 10.1016/j.clp.2017.05.004
[38]	WEJRYD E, MARTI M, MARCHINI G, et al. Low diversity of human milk oligosaccharides is associated with necrotising enterocolitis in extremely low birth weight infants[J]. Nutrients,2018,10(10):1556. doi: 10.3390/nu10101556
[39]	LIN P W, STOLL B J. Necrotising enterocolitis[J]. The Lancet,2006,368(9543):1271−1283. doi: 10.1016/S0140-6736(06)69525-1
[40]	NINO D F, SODHI C P, HACKAM D J. Necrotizing enterocolitis: New insights into pathogenesis and mechanisms[J]. Nature Reviews Gastroenterology & Hepatology,2016,13(10):590−600.
[41]	ROZE JC, ANCEL PY, LEPAGE P, et al. Nutritional strategies and gut microbiota composition as risk factors for necrotizing enterocolitis in very-preterm infants[J]. American Journalof Clinical Nutrition,2017,106(3):821−830. doi: 10.3945/ajcn.117.152967
[42]	SODHI C P, WIPF P, YAMAGUCHI Y, et al. The human milk oligosaccharides 2'-fucosyllactose and 6'-sialyllactose protect against the development of necrotizing enterocolitis by inhibiting toll-like receptor 4 signaling[J]. Pediatric Research,2020,10:1038.
[43]	GOOD M, SODHI C P, YAMAGUCHI Y, et al. The human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine[J]. British Journal of Nutrition,2016,116(7):1175−1187. doi: 10.1017/S0007114516002944
[44]	WANG C, ZHANG M, GUO H, et al. Human milk oligosaccharides protect against necrotizing enterocolitis by inhibiting intestinal damage via increasing the proliferation of Crypt cells[J]. Molecular Nutrition & Food Research,2019,63(18):1900262.
[45]	AUTRAN CA, SCHOTERMAN MH, JANTSCHER-KREEN E, et al. Sialylated galacto-oligosaccharides and 2'-fucosyllactose reduce necrotising enterocolitis in neonatal rats[J]. British Journal of Nutrition,2016,116(2):294−299. doi: 10.1017/S0007114516002038
[46]	CILIEBORG MS, BERING SB, ØSTERGAARD MV, et al. Minimal short-term effect of dietary 2'-fucosyllactose on bacterial colonisation, intestinal function and necrotising enterocolitis in preterm pigs[J]. British Journal of Nutrition,2016,116(5):834−841. doi: 10.1017/S0007114516002646
[47]	AUTARN C A, KELLMAN B P, KIM J H, et al. Human milk oligosaccharide composition predicts risk of necrotising enterocolitis in preterm infants[J]. Gut,2018,67(6):1064−1070. doi: 10.1136/gutjnl-2016-312819
[48]	KOTLOFF KL, NASRIN D, BLACKWELDER WC, et al. The incidence, aetiology, and adverse clinical consequences of less severe diarrhoeal episodes among infants and children residing in low-income and middle-income countries: A 12-month case-control study as a follow-on to the Global Enteric Multicenter Study (GEMS)[J]. Lancet Global Health,2019,7(5):e568−e584. doi: 10.1016/S2214-109X(19)30076-2
[49]	WANG Y, ZOU Y, WANG J, et al. The protective effects of 2'-fucosyllactose against E. Coli O157 infection are mediated by the regulation of gut microbiota and the inhibition of pathogen adhesion[J]. Nutrients,2020,12(5):1284. doi: 10.3390/nu12051284
[50]	CILIEBORG M S, SANGILD P T, JENSEN M L, et al. α1, 2-Fucosyllactose does not improve intestinal function or prevent escherichia coli F18 diarrhea in newborn pigs[J]. Journal of Pediatric Gastroenterology and Nutrition,2017,64(2):310−318. doi: 10.1097/MPG.0000000000001276
[51]	MORROW A L, RUIZ-PALACIOS G M, et al. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea[J]. Journal of Nutrition,2005,135(5):1304−1307. doi: 10.1093/jn/135.5.1304
[52]	YU Z T, NANTHAKUMAR N N, NEWBURG D S. The human milk oligosaccharide 2'-Fucosyllactose quenches campylobacter jejuni-induced inflammation in human epithelial cells HEp-2 and HT-29 and in mouse intestinal mucosa[J]. Journal of Nutrition,2016,146(10):1980−1990. doi: 10.3945/jn.116.230706
[53]	SCHROTEN H, HANISCH F G, HANSMAN G S. Human norovirus interactions with Histo-Blood group antigens and human milk oligosaccharides[J]. Journal of Virology,2016,90(13):5855−5859. doi: 10.1128/JVI.00317-16
[54]	LAUCIRICA D R, TRIANTIS V, SCHOEMAKER R, et al. Milk oligosaccharides inhibit human rotavirus infectivity in MA104 cells[J]. Journal of Nutrition,2017,147(9):1709−1714.
[55]	NATIVIDAD J M, RYTZ A, KEDDANI S, et al. Blends of human milk oligosaccharides confer intestinal epithelial barrier protection in vitro[J]. Nutrients,2020,12(10):3047. doi: 10.3390/nu12103047

[1]	XU Yi, BAI Yuwu, ZHAO Yuying, YANG Chao, DENG Shanggui, GAO Yuanpei. Quality Changes of Large Yellow Croaker Meat with Different Cooked Degrees during Frozen Storage and Reheating Process[J]. Science and Technology of Food Industry, 2025, 46(6): 138-146. DOI: 10.13386/j.issn1002-0306.2024040459
[2]	WU Sifen, TU Zongcai, GUO Debin, HU Xinyan, LI Jinlin, LUO Yiyong, HU Mingming. Changes in Quality of Sauced Duck Necks during Cold Storage and Its Correlation with Microbial Community[J]. Science and Technology of Food Industry, 2024, 45(16): 319-327. DOI: 10.13386/j.issn1002-0306.2023100227
[3]	GE Zhiqin, CHEN Zhe, YU Dawei, XIA Wenshui, XU Yanshun. Quality Changes of Pre-fried Fish during Frozen and Reheating Process[J]. Science and Technology of Food Industry, 2024, 45(4): 267-272. DOI: 10.13386/j.issn1002-0306.2023040031
[4]	WANG Zhengyun, LI Ting, LIU Zixiao, YUAN Zhi, JIANG Huiliang, ZHAN Yueping. Quality Changes of Grass Carp Visceral Fish Oil under Different Storage Temperatures[J]. Science and Technology of Food Industry, 2023, 44(1): 362-368. DOI: 10.13386/j.issn1002-0306.2022040031
[5]	ZHANG Jingjing, WANG Yan, LIU Xiaoxiao, WU Fuxiang, PAN Jianzhong, HU Fangdi. Quality Change of Flaxseed Oil during Frying Process[J]. Science and Technology of Food Industry, 2022, 43(16): 50-58. DOI: 10.13386/j.issn1002-0306.2021110150
[6]	HUANG Yechuan, WANG Yang, GOU Xingneng, PENG Chunlei, ZHANG Xicai. The Quality Changes of Two Fermented Sausages under Different Storage Temperatures and the Establishment of Prediction Models for Their Shelf Life[J]. Science and Technology of Food Industry, 2022, 43(7): 343-351. DOI: 10.13386/j.issn1002-0306.2021070158
[7]	ZHANG Li, MA Ji-bing, WANG Yan, DONG Chao, CUI Wen-bing, YU Qun-li, HAN Ling. Quality change during processing of dried yak meat in pastoral areas of Gansu[J]. Science and Technology of Food Industry, 2017, (21): 1-6. DOI: 10.13386/j.issn1002-0306.2017.21.001
[8]	WEI Yi-nong, JIA Min, ZHANG Tao, XUE Yong, XUE Chang-hu, LI Zhao-jie, WANG Yu-ming. Quality changes and optimization of different abalones during heat processing[J]. Science and Technology of Food Industry, 2017, (15): 181-184. DOI: 10.13386/j.issn1002-0306.2017.15.034
[9]	DONG Yi-wei, GUO Quan-you, LI Bao-guo, JIANG Chao-jun, GU Tian-sheng. Identification of dominated spoilage organisms and quality changes in lightly salted Mylopharyngodon piceus during processing and storage[J]. Science and Technology of Food Industry, 2015, (23): 306-310. DOI: 10.13386/j.issn1002-0306.2015.23.055
[10]	XU Hui-wen, XIE Jing, TANG Yuan-rui, CHEN Yu-zhou, ZHANG Ning, LI Nian-wen, PAN Wen-long. Study on the permeability of salt and quality change of tuna by the brine solution immersion freezing[J]. Science and Technology of Food Industry, 2014, (12): 349-353. DOI: 10.13386/j.issn1002-0306.2014.12.068

Supplements (0)

Cited By

Cited by

Periodical cited type(6)

1.	王菊花，许佳敏，佟祎鑫，彭淑婷，白万明，白小勇，孔维宝. 米糠蜡添加量对亚麻籽油基油凝胶结构及性质的影响. 中国油脂. 2023(07): 17-22 .
2.	韩春然，修伟业，李广志，黎晨晨，遇世友，刘晓飞. 复合助溶剂对果汁中番茄红素溶出量的影响. 包装工程. 2021(01): 32-38 .
3.	廖振林，李倩滢，陈俊杰，杜李宇，王洁，方祥. 亚麻籽油组分的功能活性研究进展. 现代食品科技. 2021(11): 337+379-389 .
4.	王敏，周劲杰，谢媛媛，王婷婷，占剑峰，王蔚新. 板栗壳多酚对食用油脂的抗氧化作用. 食品工业. 2020(01): 148-151 .
5.	全力. 番茄红素的抗氧化性研究进展. 当代临床医刊. 2020(02): 193-194 .
6.	葛宇飞，朱冰瑶，方晶晶，徐丽珊. 龙眼核油脂成分及其抗氧化活性分析. 中国粮油学报. 2020(10): 91-95 .

Other cited types(4)

Get Citation

PDF

XML

Article Metrics

Article views (215) PDF downloads (21) Cited by(10)

Science and Technology of Food Industry

Protective Effect of 2'-Fucosyllactose on Necrotizing Enterocolitis and Infectious Diarrhea in Infants